Related references
Note: Only part of the references are listed.Study of the preanalytical variables affecting the measurement of clinically relevant free-circulating microRNAs: focus on sample matrix, platelet depletion, and storage conditions
Martina Faraldi et al.
BIOCHEMIA MEDICA (2020)
Impact of long-term storage and freeze-thawing on eight circulating microRNAs in plasma samples
Pamela R. Matias-Garcia et al.
PLOS ONE (2020)
Circulating miR-141 and miR-375 are associated with treatment outcome in metastatic castration resistant prostate cancer
A. H. Zedan et al.
SCIENTIFIC REPORTS (2020)
A Tetra-Panel of Serum Circulating miRNAs for the Diagnosis of the Four Most Prevalent Tumor Types
Belen Pastor-Navarro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
miRNA in prostate cancer: challenges toward translation
Irena Abramovic et al.
EPIGENOMICS (2020)
The relationship of human tissue microRNAs with those from body fluids
Chunmei Cui et al.
SCIENTIFIC REPORTS (2020)
Profiling of Circulating microRNAs in Prostate Cancer Reveals Diagnostic Biomarker Potential
Jacob Fredsoe et al.
DIAGNOSTICS (2020)
Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review
Christopher J. McNally et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients
Venhar Gurbuz et al.
GENE (2020)
Association of High miR-182 Levels with Low-Risk Prostate Cancer
Bethany Baumann et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology
Giovanni Ponti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer
Ionut Andrei Paunescu et al.
MEDICINA-LITHUANIA (2019)
Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
David Bidarra et al.
FRONTIERS IN ONCOLOGY (2019)
Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis
Maria Barcelo et al.
SCIENTIFIC REPORTS (2019)
MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway
Dawei Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Increased levels of serum miR-148a-3p are associated with prostate cancer
Sandra Amalie Dybos et al.
APMIS (2018)
Liquid Biopsy Potential Biomarkers in Prostate Cancer
Jochen Neuhaus et al.
DIAGNOSTICS (2018)
Plasma microRNA signature is associated with risk stratification in prostate cancer patients
Abeer Al-Qatati et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
miRNAs associated with prostate cancer risk and progression
Hung N. Luu et al.
BMC UROLOGY (2017)
Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations
Charlotte Glinge et al.
PLOS ONE (2017)
Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients
Edgars Endzelins et al.
BMC CANCER (2017)
Evaluating Droplet Digital Polymerase Chain Reaction for the Quantification of Human Genomic DNA: Lifting the Traceability Fog
Margaret C. Kline et al.
ANALYTICAL CHEMISTRY (2017)
International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading
Lars Egevad et al.
APMIS (2016)
Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway
Jingjing Yao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer
Paola Campomenosi et al.
BMC BIOTECHNOLOGY (2016)
Platelets confound the measurement of extracellular miRNA in archived plasma
Adam J. Mitchell et al.
SCIENTIFIC REPORTS (2016)
Analysis of circulating miRNAs 21 and 375 as potential biomarkers for early diagnosis of prostate cancer
Y. Gao et al.
NEOPLASMA (2016)
Seminal fluid: a useful source of prostate cancer biomarkers?
Matthew J. Roberts et al.
BIOMARKERS IN MEDICINE (2015)
Data Normalization Strategies for MicroRNA Quantification
Heidi Schwarzenbach et al.
CLINICAL CHEMISTRY (2015)
Combinations of Serum Prostate-Specific Antigen and Plasma Expression Levels of let-7c, miR-30c, miR-141, and miR-375 as Potential Better Diagnostic Biomarkers for Prostate Cancer
Darina Kachakova et al.
DNA AND CELL BIOLOGY (2015)
Diagnostic Performance of Expression of PCA3, Hepsin and miR Biomarkers Inejaculate in Combination With Serum PSA for the Detection of Prostate Cancer
Matthew J. Roberts et al.
PROSTATE (2015)
Human seminal fluid as a source of prostate cancer-specific microRNA biomarkers
Luke A. Selth et al.
ENDOCRINE-RELATED CANCER (2014)
Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer
S. Mishra et al.
ONCOGENE (2014)
Absolute quantification by droplet digital PCR versus analog real-time PCR
Christopher M. Hindson et al.
NATURE METHODS (2013)
Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels
Heather H. Cheng et al.
PLOS ONE (2013)
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Gerrit Draisma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower
IM Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Share Paper
